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Abstract
Background:  Factors governing adipose tissue differentiation play a major role in obesity
development in humans. The Krüppel-like zinc finger transcription factor KLF2/Lung KLF (LKLF) is
a negative regulator of adipocyte differentiation. In this study, we sequenced the human KLF2 gene
and several common polymorphisms were found, among them the Pro104Leu and 3'UTR
1239C>A polymorphisms.
Methods: To evaluate the impact of these polymorphisms on anthropometric variables in humans,
we genotyped a general population composed of 1155 French individuals (including 232 obese
subjects) for these polymorphisms and looked for potential statistical associations with obesity-
related variables.
Results:  The frequency of the Leu104 and 1239A alleles were 0.22 and 0.18 respectively.
Genotype and allele frequencies of the two polymorphisms were comparable in obese, overweight
and normal weight subjects. No association between the rare alleles of the polymorphisms and
anthropometric variables (BMI, weight, waist and hip circumferences, waist-to-hip ratio and plasma
leptin levels) could be detected. Haplotype analyses did not reveal further significant associations.
Conclusion: These data indicate that the Pro104Leu and 3'UTR 1239C>A polymorphisms in KLF2
are not associated with obesity and obesity-related traits in humans.
Background
Obesity is recognized as a worldwide public health prob-
lem that may be the major cause of mortality in few years
time as it contributes to various severe diseases including
type 2 diabetes, atherosclerosis and cancer. The control of
adipose tissue differentiation could play an important
role in the development of obesity. Different members of
several major families, the CCAAT/enhancer-binding pro-
tein (C/EBP), peroxisome proliferator-activated receptor γ
(PPARγ) and the basic-helix-loop-helix protein ADD1/
SREBP1c (adipocyte determination and differentiation
factor-1-sterol regulatory element-binding protein-1) are
the main orchestrators of this complex pathway [1,2].
The Lung Krüppel Like zinc Finger (LKLF/KLF2) protein is
a member of the zinc finger protein family that binds to
the consensus sequence 5'-CNCCC-3'. The KLF2 gene was
cloned by Anderson and colleagues through the use of the
zinc finger domain of EKLF (erythroid Krüppel-like fac-
tor) as a bait [3]. The KLF2 gene is located at the
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19p13.11-13 locus [4]. KLF2 is expressed in the lung, the
developing vascular system, heart, skeletal muscle, kid-
ney, testis, lymphoid tissues and preadipocytes [4,5]. Pre-
vious studies demonstrated a critical role for KLF2 in T cell
activation and in vascular [6,7]. and lung development
[8]. Mice lacking KLF2 die in utero between day 11.5 and
13.5 of embryonic life and exhibit retarded growth,
craniofacial abnormalities, abdominal bleeding and signs
of anaemia [9]. Studies in 3T3-L1 and human primary
cells showed that KLF2 is expressed in preadipocytes but
not in mature adipocytes. Its overexpresion inhibits adi-
pocyte differentiation, as well as PPARγ, C/EBPα and
ADD1/SREBP1c expression [5]. Moreover, Banerjee et al.
showed that KLF2 can directly inhibit PPARγ2 promoter
activity via a KLF2 binding site located at position -82 to -
93 bp in the mouse PPARγ2 promoter. This raises the pos-
sibility that KLF2 might be involved in body weight con-
trol in humans. In order to evaluate the importance of
KLF2 in body weight control in humans, we searched for
genetic polymorphisms in the gene and looked for their
associations with anthropometric variables in a represent-
ative sample of the northern French population (n =
1155).
Methods
Population study
Within the framework of the WHO-MONICA (Multina-
tional MONItoring of trends and determinants of CArdi-
ovascular diseases) project [10,11], we constituted in
1995–1997 an age (35–64 years)- and gender-stratified
sample of men (n = 601) and women (n = 594) living in
the Urban Community of Lille in northern France. This
study was randomly sampled from the electoral rolls. To
our knowledge, there were no related subjects in the sam-
ple. The Ethics Committee of the Centre Hospitalier et
Universitaire de Lille approved this study and informed
consent was obtained from each individual. A detailed
questionnaire was completed, which included an evalua-
tion of alcohol and smoking consumption and a personal
medical history. Body mass index (BMI), waist-to-hip
ratio (WHR) and blood pressure were measured.
Genomic DNA was available for 1155 subjects. From this
sample, 232 subjects were obese (BMI ≥ 30 kg/m2). The
level of physical activity was defined as: walking or cycling
15 min or more per day, and/or lifting or carrying heavy
objects at work daily, and/or doing sport or physical exer-
cise more than 2 hours a week. Current cigarette smokers
were defined as subjects reporting at least one cigarette per
day. Total alcohol intake was expressed as the sum of ml
of alcohol per week from wine, beer, cider and spirits.
Sequencing of the KLF2 gene
The KLF2 gene was amplified and sequenced using the fol-
lowing oligonucleotides: For the exons 1 and 2: 5'-
ATGGCGCTGAGTGAACCC-3' (position 1 of the ATG)
and 5'-CATCTGCGCACGCACACAG-3' (end of exon 2).
The corresponding PCR (1109 bp) was then sequenced
with these oligonucleotides as well as the intermediate
oligonucleotides 5'-GCGGCCTGCAGGAGGTGAG-3'
(end of exon 1), 5'-CTGCAGACTCAGGAGAGG-3' (posi-
tion 98 in intron 1) and 5'-GCGGCTTCGTGCATGCGA-3'
(position 390 in exon 2). For the exon 3: 5'-GGTGAG-
GATCCGGATTGT-3' (position 639 in intron 2) and 5'-
GGATCGAGGCTTGTGATGC-3' (position 289 after the
stop codon).
Genotyping
Pro104Leu polymorphism
The region encompassing the polymorphism was ampli-
fied using the following oligonucleotides: sense 5'-
GCGCCGAACCCGAGTCCG-3' and antisense 5'-GCG-
GTCCACGGGTCAGCC-3'. The PCR reaction was per-
formed using 1 mM MgCl2 at an annealing temperature of
60°C. The PCR product (348 bp) was digested with 1 unit
of BseYI (New England Biolabs, Hertfordshire, UK). The
digestion product was resolved on 2% agarose gels. The
Leu104 allele is cut by BseYI into 2 fragments of 224 and
124 bp whereas the Pro104 allele is not cut.
3'UTR 1239C>A polymorphism
A forced enzymatic restriction site for the HaeIII enzyme
was introduced into the forward primer 5'-
ACGACGCCACCACCCCGGC-3' and was used with the
reverse primer 5'-GCATCACAAGCCTCGATCC-3' to gen-
erate a 157 bp amplicon. The annealing temperature of
the primers was 66°C and 2 mM MgCl2 was used in the
Table 1: Linkage disequilibrium between the Pro104Leu and 3'UTR 1239C>A polymorphisms
Pro104Leu
Pro104Pro Pro104Leu Leu104Leu Total
3'UTR 1239C>A CC 421 (37.4) 284 (25.2) 54 (4.8) 759
CA 233 (20.7) 97 (8.6) 4 (0.4) 334
AA 28 (2.5) 4 (0.4) 0 (0) 32
Total 682 385 58 1125
Data are n (%).
D' = -0.75 and r2 = 0.035.
Only subjects with genotypes available for both polymorphisms are represented in the table.BMC Medical Genetics 2006, 7:26 http://www.biomedcentral.com/1471-2350/7/26
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PCR reaction. The PCR product was then digested by 1
unit of HaeIII (New England Biolabs, Hertfordshire, UK)
and the digestion product was separated on a 14% acryla-
mide gel (acrylamide, bis-acrylamide 19:1). HaeIII cuts
the PCR into 3 fragments in case of the 1239C allele
(17+20+120 bp) whereas 2 fragments are generated
(37+120 bp) in case of the 1239A allele.
Statistical analyses
Genotype associations
Allele frequencies were estimated by gene-counting and
departure from Hardy-Weinberg equilibrium within the
study groups was tested using a χ2 test. Three groups of
BMI were considered according to WHO definitions: nor-
mal weight (BMI<25 kg/m2), overweight (25 ≤ BMI<30
kg/m2) and obese (BMI ≥ 30 kg/m2) KLF2 genotype effects
were tested by gender on anthropometrical variables by
analysis of variance (procedure GLM) with and without
adjustment for covariates (age, physical activity, smoking
and alcohol consumptions) using a dominant model
(heterozygotes combined with homozygotes for the rare
allele versus homozygotes for the common allele). Leptin
values were log-transformed to obtain normal distribu-
tions. Throughout, p-values < 0.05 were interpreted as sig-
nificant. All genotype analyses were carried out with the
SAS software (version 8, SAS Institute, Cary, NC). Power
calculations were based on a two-sided, two-sample
(dominant model), t-test, with a power of 0.80, an α of
0.05, and the means and standard deviations of BMI dis-
played in tables 3 and 4, in men and women respectively.
Haplotype analyses
were based on the maximum likelihood model described
in [12] and linked to the SEM algorithm [13] imple-
mented in the THESIAS program [14]. By definition, the
reference haplotype corresponds to the more frequent
haplotype.
Results
The human KLF2 gene is composed of three exons and
two introns. Exons 1, 2 and 3 as well as all intron 1 and
the last 183 bp of intron 2 were sequenced in 10 (5 obese
and 5 non-obese) subjects. Three polymorphisms were
detected: a C/T substitution in intron 1 (rs7248864,
75+44C>T, T allele frequency <10%), a C/T polymor-
phism in exon 2 replacing a proline with a leucine at
codon 104 (rs3745318, Pro104Leu, Leu104 frequency
around 20%), and a C/A polymorphism in the 3'UTR
1239 nucleotides after the first coding nucleotide (or 171
nucleotides after the STOP codon) (rs15336, 1239C>A,
1239A allele frequency around 15%). These polymor-
phisms, by the end of this study, were all displayed on the
NCBI dbSNP web site. We were unable to amplify and
sequence the proximal promoter of KLF2 (up to 400 bp
upstream the ATG) despite attempts with several pairs of
primers. However, one SNP (rs8106384, -18T>C) in the
5'UTR (18 bp before the ATG) was displayed on the NCBI
dbSNP web site. We tested for the existence of this poly-
morphism but found only one heterozygote in 59 individ-
uals (-18T allele frequency < 1%). We therefore decided to
genotype the Lille population study for the Pro104Leu
and 3'UTR 1239C>A polymorphisms as they were fre-
quent enough to give sufficient statistical power and were
more likely to have a functional impact at the protein or
gene expression level.
There were 60.8% of Pro104Pro, 34.0% of Pro104Leu and
5.2% of Leu104Leu individuals (Leu104 allele frequency =
0.22) and 67.6% of 1239CC, 29.6% of 1239CA and 2.8%
of 1239AA individuals (1239A allele frequency = 0.18) in
the population. These distributions were not different
Table 2: Genotype and allele frequencies of the Pro104Leu and 3'UTR 1239C>A polymorphisms according to obesity status by 
gender.
Men Women
Normal 
weight
Overweight Obese p* Normal 
weight
Overweight Obese p*
Pro104Pro, n (%) 140 (60.9) 147 (60.8) 61 (59.2) 153 (59.5) 103 (59.2) 83 (65.4)
Pro104Leu, n (%) 83 (36.1) 78 (32.2) 37 (35.9) 0.36 90 (35.0) 60 (34.5) 40 (31.5) 0.67
Leu104Leu, n (%) 7 (3.0) 17 (7.0) 5 (4.9) 14 (5.5) 11 (6.3) 4 (3.1)
Total 230 242 103 257 174 127
1239CC, n (%) 162 (69.5) 158 (66.1) 67 (65.1) 176 (68.8) 119 (68.4) 84 (65.6)
1239CA, n (%) 62 (26.6) 72 (30.1) 34 (33.0) 0.69 74 (28.9) 53 (30.5) 40 (31.3) 0.78
1239AA, n (%) 9 (3.9) 9 (3.8) 2 (1.9) 6 (2.3) 2 (1.1) 4 (3.1)
Total 233 239 103 256 174 128
* p values for the 3*3 analysis.
Normal weight: BMI < 25 kg/m2, overweight: 25 ≤ BMI < 30 kg/m2, obese: BMI ≥ 30 kg/m2.BMC Medical Genetics 2006, 7:26 http://www.biomedcentral.com/1471-2350/7/26
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from the frequencies expected in a population in Hardy-
Weinberg equilibrium. The two polymorphisms were in
partial linkage disequilibrium, the Pro104 allele being
associated with the 1239A allele (D' = -0.75, p < 0.0001)
whilst the two SNPs did not give the same information (r2
= 0.035) (table 1).
Because anthropometric variables and obesity status differ
significantly according to gender, we assessed the impact
of the KLF2 polymorphisms in men and women sepa-
rately in the analyses. The genotype and allele distribu-
tions for both polymorphisms were similar in lean
(BMI<25 kg/m2), overweight (25 ≤ BMI>30 kg/m2) or
obese (BMI ≥ 30 kg/m2) individuals in men and women
independently (table 2).
We then looked for potential associations between the
rare (Leu104 and 1239A) alleles of the polymorphisms
and anthropometric variables (body weight, BMI, waist
and hip circumferences, WHR, plasma leptin levels). No
significant differences could be detected between
Pro104Pro individuals and Leu104 allele bearers or
between 1239CC and 1239A allele bearers concerning
these phenotypes (tables 3 and 4) even after adjustment
for age, smoking and alcohol consumption and physical
activity level, in either men or women.
We also performed haplotype analyses in order to study
allele combinations. The frequency of the haplotype com-
prising the 2 common alleles (Pro104-1239C) was
around 60%. The frequencies of the 4 possible haplotypes
were similar in obese and non-obese subjects (table 5).
No significant global effect of haplotypes could be
detected in either men or women for any quantitative var-
iables considered (body weight, BMI, waist and hip cir-
cumferences, WHR or plasma leptin levels) (data not
shown).
Discussion
To our knowledge, this is the first time the study of poly-
morphisms in the KLF2 gene have been undertaken. Fol-
lowing the observations from Banerjee et al. who showed
KLF2 is a negative regulator of adipocyte differentiation
and that it directly inhibits PPARγ [5], one of the key reg-
ulators of adipose tissue differentiation, we hypothesised
that KLF2 may be a candidate gene for body weight and fat
mass control in humans. We identified several polymor-
phisms in KLF2 and genotyped the Lille population study
for two of them, one in the coding region (Pro104Leu)
and the other in the 3' untranslated region (1239C>A) of
the gene. We could not observe any significant association
between the polymorphisms and obesity status or anthro-
pometric variables in our sample, by individual or haplo-
type analyses.
Table 3: Impact of the Pro104Leu polymorphism on obesity-related traits by gender.
Men Women
n Pro104Pro 348 Pro104Leu 198 Leu104Leu 29 p* Pro104Pro 341 Pro104Leu 190 Leu104Leu 29 p*
Weight, kg 80.0 ± 13.2 79.0 ± 14.1 83.9 ± 10.9 0.77 69.1 ± 15.0 68.8 ± 15.9 67.7 ± 15.2 0.76
BMI, kg/m2 26.6 ± 4.1 26.5 ± 4.3 27.5 ± 2.5 0.91 26.8 ± 5.7 26.7 ± 6.0 25.5 ± 4.9 0.70
Waist, cm 96.1 ± 10.9 95.8 ± 11.1 97.8 ± 7.9 0.98 86.1 ± 14.6 86.0 ± 14.9 84.7 ± 13.7 0.83
Hip, cm 101.7 ± 7.5 101.2 ± 7.4 102.0 ± 5.6 0.59 104.0 ± 12.1 104.2 ± 12.5 103.1 ± 14.5 0.93
WHR 0.94 ± 0.07 0.95 ± 0.07 0.96 ± 0.07 0.54 0.83 ± 0.08 0.82 ± 0.08 0.82 ± 0.08 0.59
Leptin, ng/ml 9.5 ± 7.8 8.8 ± 7.1 9.8 ± 6.7 0.78 24.1 ± 14.1 23.3 ± 13.9 24.6 ± 14.4 0.64
* for the comparison between Pro104Pro vs Leu/* subjects.
Table 4: Impact of the 1239C>A polymorphism on obesity-related traits by gender
Men Women
n CC 387 CA 168 AA 20 p* CC 381 CA 167 AA 12 p*
Weight, kg 79.7 ± 13.4 80.1 ± 13.8 78.9 ± 12.1 0.85 69.2 ± 16.0 68.6 ± 13.6 68.3 ± 12.4 0.67
BMI, kg/m2 26.5 ± 4.1 26.8 ± 4.2 25.5 ± 3.6 0.62 26.7 ± 6.0 26.6 ± 5.4 26.9 ± 5.2 0.85
Waist, cm 96.0 ± 10.8 96.5 ± 10.9 93.1 ± 9.4 0.85 86.1 ± 15.2 85.9 ± 13.3 90.6 ± 13.0 0.97
Hip, cm 101.4 ± 7.1 102.0 ± 8.0 100.8 ± 6.2 0.48 104.1 ± 12.9 104.0 ± 11.3 104.0 ± 10.9 0.92
WHR 0.95 ± 0.07 0.95 ± 0.07 0.92 ± 0.07 0.72 0.83 ± 0.08 0.82 ± 0.08 0.87 ± 0.08 0.75
Leptin, ng/ml 9.4 ± 7.3 9.0 ± 8.2 7.5 ± 4.9 0.13 24.0 ± 14.3 23.5 ± 13.5 28.6 ± 14.7 0.93
* for the comparison between CC and CA+AA subjectsBMC Medical Genetics 2006, 7:26 http://www.biomedcentral.com/1471-2350/7/26
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The KLF2 protein is rich in proline residues (17.5% of the
total residues) and form Pro-rich repeats of three to eight
amino acids in a row [4]. Conkright et al. showed amino
acids 1–100 of KLF2 correspond to the activation domain
of the protein [15]. The polymorphism at codon 104
(Pro>Leu) is located outside the activation domain but it
replaces a proline by a leucine and might therefore modify
the structure and the activity of the protein. However,
when comparing rodent and human sequences, a
glutamine residue is present at codon 104 in the murine
and rat sequences instead of a proline residue in humans,
suggesting this amino acid is probably not crucial for the
protein function. Because the 1239C>A polymorphism is
located into the 3' untranslated region of KLF2, it could
potentially modify the gene expression or mRNA stability
but this remains to be determined. Also, it remains possi-
ble these polymorphisms are in linkage disequilibrium
with other functional variant(s) nearby that remains to be
detected.
Our study has both strengths and weaknesses. It was con-
ducted in a large random sample of population which
avoids possible bias due to recruitment in hospitals or
clinics and university staff or students. The analyses were
performed in men and women separately which is an
important advantage with regard to the impact of gender
on fat mass depots and obesity risk. A difference in BMI
between genotype groups should be at least of 1 kg/m2 to
be considered phenotypically relevant. The population-
study we used was powerful enough (power ≥ 80%, α =
5%) to detect a difference in BMI of 1.0 and 1.4 kg/m2 in
men and women respectively for both polymorphisms.
The major limitation of the study may be that only two
SNPs in KLF2  were studied and therefore we can not
totally exclude that other SNPs in or nearby (especially in
regulatory regions) the KLF2 gene might be associated
with obesity traits.
Conclusion
In conclusion, the Pro104Leu and 1239C>A polymor-
phisms in KLF2  were not associated with obesity and
obesity-related traits in a large representative sample of
French men and women.
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